Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 29:2021:9536730.
doi: 10.1155/2021/9536730. eCollection 2021.

Association between Neutrophilic Granulocyte Percentage and Diabetes Mellitus in Cushing's Syndrome Patients: A Cross-Sectional Study

Affiliations

Association between Neutrophilic Granulocyte Percentage and Diabetes Mellitus in Cushing's Syndrome Patients: A Cross-Sectional Study

Baomin Wang et al. Int J Endocrinol. .

Abstract

Background: Glucose metabolism is frequently impaired in patients with Cushing's syndrome (CS) due to chronic exposure to excess glucocorticoids. Inflammation plays an essential role in the pathophysiology of diabetes mellitus (DM). The present study aimed to investigate the potential associations of inflammatory blood cell parameters, including white blood cell (WBC) count, neutrophil count, neutrophilic granulocyte percentage (NEUT%), lymphocyte count (LYM), and lymphocyte proportion (LYM%), with diabetes mellitus in Cushing's syndrome patients.

Materials and methods: The cross-sectional study was conducted in Zhongshan Hospital of Fudan University, China. A total of 150 patients with Cushing's syndrome were retrospectively screened from 2017 to 2019. The demographic data, clinical data, and blood samples (lipids, adrenal, glucose, and inflammatory blood cell parameters) were recorded. Statistical analyses were carried out by using the SPSS software package, version 13.0.

Results: In this study, the prevalence of diabetes mellitus was 38.7% in patients with Cushing's syndrome. Patients with DM had higher WBC, neutrophil, NEUT% levels than patients without DM (p < 0.05). As the NEUT% increased, a stepwise increase in glucose and glycated hemoglobin (HbA1c) level was observed. In addition, in the multivariate logistic regression, NEUT% was a significant independent risk factor for DM, regardless of gender, age, body mass index (BMI), and triglyceride and 12 midnight cortisol (12 MN cortisol) level (OR = 2.542, 95% CI 1.337-4.835, p < 0.001).

Conclusions: In conclusion, elevated NEUT% level was linked to diabetes in patients with Cushing's syndrome. The neutrophilic granulocyte percentage may be referred to as a new predictor for diabetes in Cushing's syndrome patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The percentage of neutrophils is associated with impaired glucose metabolism in patients with Cushing's syndrome. (a) Neutrophilic granulocyte percentage (NEUT%) levels are much higher in DM patients than in non-DM. (b) Fasting glucose (FBG) levels are positively correlated with the percentage of neutrophilic granulocyte. (c) Levels of 2-hour postprandial blood glucose (2hPG) are positively correlated with the percentage of neutrophilic granulocyte. (d) Glycated hemoglobin (HbA1c) is positively correlated with the percentage of neutrophilic granulocyte.

Similar articles

References

    1. Arnaldi G., Angeli A., Atkinson A. B., et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. Journal of Clinical Endocrinology & Metabolism . 2003;88(12):5593–5602. doi: 10.1210/jc.2003-030871. - DOI - PubMed
    1. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism) 1. Obesity Research . 1994;2(5):486–508. doi: 10.1002/j.1550-8528.1994.tb00097.x. - DOI - PubMed
    1. Giraldi F. P., Moro M., Cavagnini F. Gender-related differences in the presentation and course of Cushing’s disease. Journal of Clinical Endocrinology & Metabolism . 2003;88(4):1554–1558. doi: 10.1210/jc.2002-021518. - DOI - PubMed
    1. Giustina A., Porcelli T., Giustina A. Treatment of Cushing disease: overview and recent findings. Therapeutics and Clinical Risk Management . 2010;6:505–516. doi: 10.2147/tcrm.S12952. - DOI - PMC - PubMed
    1. Patil C. G., Prevedello D. M., Lad S. P., et al. Late recurrences of Cushing’s disease after initial successful transsphenoidal surgery. Journal of Clinical Endocrinology & Metabolism . 2008;93(2):358–362. doi: 10.1210/jc.2007-2013. - DOI - PubMed